Codiak BioSciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Codiak BioSciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2020 to Q3 2022.
  • Codiak BioSciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $21M, a 1.43% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $21M -$303K -1.43% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $21.3M -$215K -1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $21.6M -$129K -0.59% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $22M -$46K -0.21% Dec 31, 2021 10-Q 2022-11-03
Q3 2021 $21.3M -$968K -4.36% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $21.5M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $21.8M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $22M Dec 31, 2020 10-K 2022-03-10
Q3 2020 $22.2M Sep 30, 2020 10-Q 2020-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.